Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy

BACKGROUND AND AIM: Sepsis is a syndromic response to infection and is associated with high mortality, thus imposing a significant global burden of disease. Although low-molecular-weight heparin (LMWH) has been recommended to prevent venous thromboembolism, its anticoagulant and anti-inflammatory ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ze, Yan, Taotao, Ren, Danfeng, Zhou, Jingwen, Liu, Liangru, Li, Juan, Fu, Shan, Ni, Tianzhi, Xu, Weicheng, Yang, Yuan, Chen, Tianyan, He, Yingli, Zhao, Yingren, Liu, Jinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289000/
https://www.ncbi.nlm.nih.gov/pubmed/37359014
http://dx.doi.org/10.3389/fmed.2023.1157775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289000/
https://www.ncbi.nlm.nih.gov/pubmed/37359014
http://dx.doi.org/10.3389/fmed.2023.1157775

Ejemplares similares